tetano
Editor, Senior Moderator
Eur J Case Rep Intern Med
. 2020 Jun 10;7(7):001768.
doi: 10.12890/2020_001768. eCollection 2020.
Erythematous Papular Rash: A Dermatological Feature of COVID-19
Catarina Sousa Gon?alves[SUP] 1 [/SUP], Nuno Reis Carreira[SUP] 1 [/SUP], D?lio Passos[SUP] 1 [/SUP], Ana Lu?sa Barbosa[SUP] 1 [/SUP], Ana Maria Baltazar[SUP] 1 [/SUP], Alexandra Wahnon[SUP] 1 [/SUP], Ana Mafalda Abrantes[SUP] 1 [/SUP], Pedro Miguel Garrido[SUP] 2 [/SUP], Teresa Ferreira[SUP] 1 [/SUP], Marisa Teixeira Silva[SUP] 1 [/SUP], Lourdes Alvoeiro[SUP] 1 [/SUP]
Affiliations
Abstract
COVID-19 is the clinical expression of the highly contagious severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral infection. Most patients have mild symptoms, but a significant proportion have severe or critical disease, which can include cardiac injury, sepsis, acute kidney failure and respiratory failure. It is also worth highlighting the increasing number of reported COVID-19 cases with dermatological disease/manifestations. The cutaneous clinical spectrum is wide and includes maculopapular, urticarial, varicelliform and petechial rashes, pseudo perniosis, livedo reticularis, and pityriasis rosea-like, violaceous and pustular lesions. Until the physiological mechanism is fully understood, it is important to describe these manifestations, which could help identify a typical pattern. This report describes a cutaneous manifestation in a COVID-19 patient.
Learning points: SARS-CoV-2 presents with multiple symptoms with the dermatological manifestations currently under-recognized.Clinicians should be aware of patients presenting only with cutaneous symptoms, which in some cases are the initial clinical feature of COVID-19.
Keywords: SARS-CoV-2; cutaneous manifestations.
. 2020 Jun 10;7(7):001768.
doi: 10.12890/2020_001768. eCollection 2020.
Erythematous Papular Rash: A Dermatological Feature of COVID-19
Catarina Sousa Gon?alves[SUP] 1 [/SUP], Nuno Reis Carreira[SUP] 1 [/SUP], D?lio Passos[SUP] 1 [/SUP], Ana Lu?sa Barbosa[SUP] 1 [/SUP], Ana Maria Baltazar[SUP] 1 [/SUP], Alexandra Wahnon[SUP] 1 [/SUP], Ana Mafalda Abrantes[SUP] 1 [/SUP], Pedro Miguel Garrido[SUP] 2 [/SUP], Teresa Ferreira[SUP] 1 [/SUP], Marisa Teixeira Silva[SUP] 1 [/SUP], Lourdes Alvoeiro[SUP] 1 [/SUP]
Affiliations
- PMID: 32665937
- PMCID: PMC7350964
- DOI: 10.12890/2020_001768
Abstract
COVID-19 is the clinical expression of the highly contagious severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral infection. Most patients have mild symptoms, but a significant proportion have severe or critical disease, which can include cardiac injury, sepsis, acute kidney failure and respiratory failure. It is also worth highlighting the increasing number of reported COVID-19 cases with dermatological disease/manifestations. The cutaneous clinical spectrum is wide and includes maculopapular, urticarial, varicelliform and petechial rashes, pseudo perniosis, livedo reticularis, and pityriasis rosea-like, violaceous and pustular lesions. Until the physiological mechanism is fully understood, it is important to describe these manifestations, which could help identify a typical pattern. This report describes a cutaneous manifestation in a COVID-19 patient.
Learning points: SARS-CoV-2 presents with multiple symptoms with the dermatological manifestations currently under-recognized.Clinicians should be aware of patients presenting only with cutaneous symptoms, which in some cases are the initial clinical feature of COVID-19.
Keywords: SARS-CoV-2; cutaneous manifestations.